After binding to PD-1, PD-L1 and PD-L2 exert a repressive activity of the main pathways related to T-cells survival, which dramatically affects T-cell activation and cytokine production, and hence, T-cell capacity to repress tumor cells. This evidence concerns the gene PDCD1 and neoplasm.